Trader J's Inner Circle Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Trader J's Inner Circle

NVDA 180.94

-1.5%

Dec 11 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Bradpalm1 who wrote (2793)	12/30/1998 10:34:00 PM
From: hoffy	Read Replies (4) of 56535

Wasn't getting FDA approval for some of their drugs key to ASCT getting a buyout bid. That's what we are looking for isn't it. Why would someone want to buy them out if they don't have the approval for their drugs. I thought this was a huge setback but maybe I am wrong. When will the other drugs come up for FDA review. Without approval on any drugs ASCT will never be a buyout candidate. WIth the light trading I wonder what will happen when the masses get back next week. I hope the buyout is on the table then.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next